Christophe Corpechot
Assistance Publique - Hôpitaux de Paris · INSERM UMR_S938 · Assistance Publique
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christophe Corpechot as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:16 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06443606 · Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid TherapyAssistance Publique - Hôpitaux de Paris · recruiting · BPC, Non Optimal Response to UDCA · principal investigator
- N/ANCT05961826 · COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)Institut National de la Santé Et de la Recherche Médicale, France · active not recruiting · Low Phospholipid Associated Cholelithiasis · principal investigator
- N/ANCT03630718 · Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in WomenAssistance Publique - Hôpitaux de Paris · completed · Liver Cirrhosis, Biliary · principal investigator
- Ph3NCT01654731 · Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisAssistance Publique - Hôpitaux de Paris · completed · PBC · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:16 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.N Engl J Med · 2018499 citationsRCR 21.3
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.Ann Rheum Dis · 2019333 citationsRCR 12.6
- Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.N Engl J Med · 2024274 citationsRCR 42.9
- A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.N Engl J Med · 2024252 citationsRCR 42.1
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.Hepatology · 2000241 citationsRCR 5.4
- Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Hepatology · 2023113 citationsRCR 12.7
- Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.Gastroenterology · 202299 citationsRCR 8.1